TY - JOUR
T1 - Host and environmental determinants of human milk oligosaccharides and microbiota in the Lifelines NEXT cohort
AU - Lifelines NEXT cohort
AU - Spreckels, Johanne E
AU - Kurilshikov, Alexander
AU - Fernández-Pato, Asier
AU - Liu, Fan
AU - Brushett, Siobhan
AU - Bang, Corinna
AU - Zhernakova, Daria V
AU - Kruk, Marloes
AU - Sinha, Trishla
AU - Garmaeva, Sanzhima
AU - Brandao Gois, Milla F
AU - Lopera-Maya, Esteban A
AU - Bolte, Laura A
AU - Jankipersadsing, Soesma A
AU - Franke, Andre
AU - Tytgat, Hanne L P
AU - Mottaz, Sara Colombo
AU - Fu, Jingyuan
AU - Mallon, Сyrus A
AU - van Leeuwen, Sander S
AU - Gacesa, Ranko
AU - Zhernakova, Alexandra
N1 - Copyright © 2025 The Author(s). Published by Elsevier Inc. All rights reserved.
PY - 2025/8/26
Y1 - 2025/8/26
N2 - Human milk is important for infant development, but few large studies have comprehensively investigated milk composition. Here, we characterized human milk oligosaccharides (HMOs) and milk microbiota, their shaping factors, and their links to infant gut microbiota in the longitudinal Dutch Lifelines NEXT cohort. We measured 24 HMOs in 1,542 milk samples from 524 mothers at 0.5-6 months postpartum, profiled microbiota in milk and maternal and infant feces, genotyped mothers, and recorded 174 environmental, maternal, and infant characteristics. HMO concentrations were associated with maternal genetic loci (FUT2, FUT3/FUT6, ABO, and ST3GAL6), lactation stage, and subclinical mastitis. The human milk microbiota varied during lactation and with different feeding practices. Both HMOs and milk microbiota remained stable across multiple pregnancies in the same individual. Some milk bacteria were present in infant feces, but the milk and infant fecal microbiota diverged as the infant aged. Furthermore, individual HMOs were associated with infant fecal microbiota characteristics.
AB - Human milk is important for infant development, but few large studies have comprehensively investigated milk composition. Here, we characterized human milk oligosaccharides (HMOs) and milk microbiota, their shaping factors, and their links to infant gut microbiota in the longitudinal Dutch Lifelines NEXT cohort. We measured 24 HMOs in 1,542 milk samples from 524 mothers at 0.5-6 months postpartum, profiled microbiota in milk and maternal and infant feces, genotyped mothers, and recorded 174 environmental, maternal, and infant characteristics. HMO concentrations were associated with maternal genetic loci (FUT2, FUT3/FUT6, ABO, and ST3GAL6), lactation stage, and subclinical mastitis. The human milk microbiota varied during lactation and with different feeding practices. Both HMOs and milk microbiota remained stable across multiple pregnancies in the same individual. Some milk bacteria were present in infant feces, but the milk and infant fecal microbiota diverged as the infant aged. Furthermore, individual HMOs were associated with infant fecal microbiota characteristics.
KW - Humans
KW - Milk, Human/metabolism
KW - Oligosaccharides/metabolism
KW - Female
KW - Infant
KW - Feces/microbiology
KW - Gastrointestinal Microbiome
KW - Adult
KW - Cohort Studies
KW - Microbiota
KW - Lactation
KW - Infant, Newborn
KW - Breast Feeding
KW - Pregnancy
U2 - 10.1016/j.celrep.2025.116124
DO - 10.1016/j.celrep.2025.116124
M3 - Article
C2 - 40783943
SN - 2211-1247
VL - 44
JO - Cell reports
JF - Cell reports
IS - 8
M1 - 116124
ER -